Cue Biopharma (NASDAQ:CUE) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.10) by 110 percent. This is a 107.69 percent increase over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $21.942 million. This is a 1.29K percent increase over sales of $1.576 million the same period last year.